Showing results (361-370 of 443) with videos related to

Sort By:
Pageof 45
The New England Journal of Medicine|January 24, 2014
Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's diseaseRachelle S Doody, Ronald G Thomas, Martin Farlow, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 26, 2011
AMPA workshop on challenges faced by investigators conducting Alzheimer's disease clinical trialsBruno Vellas, Alain Pesce, Philippe H Robert, et al.
Cells|June 2, 2021
The Systemic Immune Response in COVID-19 Is Associated with a Shift to Formyl-Peptide Unresponsive EosinophilsLeo Koenderman, Maarten J Siemers, Corneli van Aalst, et al.
Handchirurgie, Mikrochirurgie, Plastische Chirurgie : Organ Der Deutschsprachigen Arbeitsgemeinschaft Fur Handchirurgie : Organ Der Deutschsprachigen Arbeitsgemeinschaft Fur Mikrochirurgie Der Peripheren Nerven Und Gefasse : Organ Der V|February 15, 2019
[Antibiotic treatment of infections in burn patients - a systematic review]K S Houschyar, C Tapking, D Duscher, et al.
Rapid Communications in Mass Spectrometry : RCM|November 23, 2006
Quantitative analysis of amyloid beta peptides in cerebrospinal fluid of Alzheimer's disease patients by immunoaffinity purification and stable isotope dilution liquid chromatography/negative electrospray ionization tandem mass spectrometryTomoyuki Oe, Bradley L Ackermann, Koichi Inoue, et al.
Journal of Wound Care|June 6, 2019
Optimising management of self-inflicted burns: a retrospective reviewKhosrow S Houschyar, Christian Tapking, Dominik Duscher, et al.
The New England Journal of Medicine|July 26, 2013
A phase 3 trial of semagacestat for treatment of Alzheimer's diseaseRachelle S Doody, Rema Raman, Martin Farlow, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 16, 2013
Can we prevent Alzheimer's disease? Secondary "prevention" trials in Alzheimer's diseaseMaria C Carrillo, H Robert Brashear, Veronika Logovinsky, et al.
Alzheimer'S & Dementia (New York, N. Y.)|August 8, 2019
Magnetic resonance imaging measures of brain atrophy from the EXPEDITION3 trial in mild Alzheimer's diseaseAdam J Schwarz, Karen L Sundell, Arnaud Charil, et al.
European Journal of Human Genetics : EJHG|July 9, 2009
The Dutch founder mutation SDHD.D92Y shows a reduced penetrance for the development of paragangliomas in a large multigenerational familyErik F Hensen, Jeroen C Jansen, Maaike D Siemers, et al.
Pageof 45